Paclitaxel (Taxol®) Mechanisms of Resistance

This publication has 53 references indexed in Scilit:

• Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer
  European Journal Of Cancer, 1995
• Retroviral Mediated Transfer of the Human Multidrug Resistance Gene (MDR-1) into Hematopoietic Stem Cells During Autologous Transplantation after Intensive Chemotherapy for Metastatic Breast Cancer. National Institutes of Health, Bethesda, Maryland
  Human Gene Therapy, 1994
• Paclitaxel-induced cytotoxicity—the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein
  European Journal Of Cancer, 1994
• Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant Phenotype
  JNCI Journal of the National Cancer Institute, 1993
• Is Cremophor EL, solvent for paclitaxel, cytotoxic?
  The Lancet, 1993
• Effects of taxotere on murine and human tumor cell lines
  Biochemical and Biophysical Research Communications, 1992
• Influence of myc overexpression on the phenotypic properties of Chinese hamster lung cells resistant to antitumor agents
  Experimental Cell Research, 1991
• Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly.
  The Journal of cell biology, 1983
• CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β-tubulin
  Cell, 1980
• Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent
  Inflammation Research, 1977